Correlation Engine 2.0
Clear Search sequence regions


  • activin (9)
  • COL1A1 (1)
  • EBPβ (3)
  • female (1)
  • human leiomyoma cells (1)
  • human myometrial cells (1)
  • humans (1)
  • isoform (1)
  • MAPK (3)
  • mice (3)
  • myometrium (1)
  • p38 α (1)
  • p38α (1)
  • p38α (2)
  • p38β (5)
  • sb202190 (1)
  • signal (1)
  • Sizes of these terms reflect their relevance to your search.

    The objective of this study was to investigate the role of p38-C/EBPβ signaling in leiomyoma cells and myometrial cells challenged with Activin A, and to identify specifically the isoform of p38 MAPK that mediates the effects of Activin A. The immortalization human leiomyoma cells (HuLM) and human myometrial cells (HM), and mouse myometrial tissues were treated with Activin A (4 nM) in response to p38α/β inhibition (10 μM SB202190) or depletion (p38 α/β-targeting siRNA or p38β muscle specific-knock out mice). p38 MAPK signaling molecules (p-p38 and p-C/EBPβ) and ECM components (COL1A1 and/or FN) were analyzed by Western blotting. Activin A induced ECM accumulation in leiomyoma cells and myofibroblastic transformation in myometrical cells specifically by p38β MAPK. This study is the first to demonstrate that activation of C/EBPβ by p38β MAPK may contribute to tumorigenesis and progression of Activin A-induced leiomyoma. Specific p38β inhibition may represent a novel and promising intervention for leiomyoma. Copyright © 2020 Elsevier Inc. All rights reserved.

    Citation

    Huiqiong Bao, Thomas K Sin, Guohua Zhang. Activin A induces tumorigenesis of leiomyoma via regulation of p38β MAPK-mediated signal cascade. Biochemical and biophysical research communications. 2020 Aug 20;529(2):379-385

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32703439

    View Full Text